In this podcast, William Schaffner, MD, offers tips for clinicians on communicating information to their patients regarding COVID-19 and the COVID-19 vaccines, including dispelling misinformation about the COVID-19 vaccines.

In this podcast, Chuck Vega, MD speaks about the financial implications of various treatments for patients with community-acquired bacterial pneumonia (CABP) and for the care system. He also speaks about the decision of inpatient vs outpatient care. This podcast is part 3 of a 3-part series on managing CABP.

In this podcast, Chuck Vega, MD, speaks about how clinicians determine site and duration of treatment for community-acquired bacterial pneumonia (CABP) based on patients' factors and prior treatment, including the difference in score systems used to predict the severity of CABP and the considerations for inpatient vs outpatient care. This podcast is part 2 of a 3-part series on managing CABP.

In this podcast, Chuck Vega, MD, speaks about how to treat patients with community-acquired bacterial pneumonia (CABP) and how it is managed for the most common presentations, including the typical bacterial pathogens that cause CABP, the most common symptoms, treatment guidelines, and standard workup of CABP.

In this podcast, Forest Arnold, MD, and Michael Egger, MD, speak about their study that aimed to evaluate the cost-effectiveness of adhering to treatment guidelines for community-acquired bacterial pneumonia in elderly patients who are hospitalized, including how the results of their study will impact clinical practice going forward.

In this podcast, Dana Villmore, PhD, Pa-C, discusses the diagnosis and management of fibromyalgia for primary care providers, a topic she recently presented at the 2021 American Academy of Physician Assistants Annual Conference. For more, visit www.consultant360.com

In this first podcast of a series, Dr Birnbaum, chief of rheumatology at California Pacific Medical Center in San Francisco, gives an overview of lupus nephritis and discusses the diagnosis, treatment, and challenges of this complication of systemic lupus erythematosus.

In this podcast, Andrea Cox, MD, PhD, discusses her team’s recent randomized controlled trial that examined the effectiveness of a vaccine regimen for preventing chronic hepatitis C virus infection. For more, visit www.consultant360.com

In this podcast, rheumatologists and research scientists Jeffrey Sparks, MD, and Zachary Wallace, MD, discuss the findings of their research into the outcomes of patients with rheumatoid arthritis taking DMARDs at baseline who contracted COVID-19.

At the Advances in Inflammatory Bowel Diseases regional meeting on June 19, Dr Wang, from the MD Anderson Cancer Center in Houston, Texas, discussed the management of colitis among patients receiving immune checkpoint inhibitor therapy for cancer.